Heart Failure
Related Links
- Innovative Strategies to Optimise Heart Failure GDMT at Prince Wales Hospital’s Heart Failure Clinic
- STRONG-HF Recommended in Updated China National Heart Failure Guideline 2023
- Rapid Titration (RaT) Pathway For Optimising Heart Failure GDMT with comprising several hospitals in Northland
- Reducing Mortality and Readmission with HF Multidisciplinary Model of Care
- Screening for Occult Heart Failure (HF) in Type 2 Diabetes Mellitus (T2DM) using NT-proBNP
- Sex-specific Differences in Heart Failure
- STRONG-HF: Enhancing GDMT regimen in Asia
- Heart Failure Care Beyond City Limits: Insights from a Cardiologist
- Implementation of STRONG-HF protocol in heart failure management: an Australian perspective
- Unleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across China
- Reshaping HF Management at NHCS
- Screening & Diagnosis of Heart Failure in Pre-Diabetic and Diabetic Patients
- Elevating CVD management in APAC to its Zenith- with Cardiac biomarkers
- Quantum leap in reducing rehospitalization in HF by 70-80% - How and where?
- Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment
- Download APAC STRONG-HF Master Pack: First-hand Insights from Prof Mebazaa on Heart Failure Treatment Monitoring
- Heart Failure Management in India - Overcoming Present Challenges
- STRONG-HF Trial highlighting benefits of treatment optimisation
- STRONG-HF: Implementation of GDMT Heart Failure Therapy & Post-discharge Heart Failure Management
- NT-proBNP and ECHO in heart failure - do they always go hand in hand?
- APAC Heart Failure Gap Report
- Value of NT-ProBNP for Treatment Monitoring in CHF
- Clinical Application NT-proBNP in CKD (Chronic Kidney Diseases) Patients with Cardiovascular Diseases
- Management of Diabetes in Japan - Can Patients Play a More Significant Role?
- T2DM Patient Support Program in Hong Kong and the Value of NT-proBNP
- 2021 ESC Heart Failure Guidelines: What's new?
- Advantages of early NT-proBNP testing in patients suspected with heart failure
- NT-proBNP: Increasing Clinical Confidence in Heart Failure Management
- Heart Failure in Asia - Present Challenges and Future Strategies
- Heart Failure Prevention in T2DM - Essence of JCS/JDS joint consensus
- BNP vs NT-proBNP: An Expert View
- Impact of ARNi Therapy on Natriuretic Peptide Use